The benefits of insulin therapy following acute myocardial infarction revisited

QJM: An International Journal of Medicine

Volumn 99, Issue 9, 2006, Pages 635-637

  Soran, H ^a   Barzangy, B ^b   Younis, N ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; LIFESTYLE; MORBIDITY; MORTALITY; MULTIPLE DRUG DOSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33749633513     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl086     Document Type: Article

References (18)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and non diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-34.
2. Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A. Mortality and morbidity during a five year follow-up of diabetes with myocardial infarction. Acta Med Scand 1988; 224:31-81.
3. Herlitz J, Bang A, Karlson BW. Mortality, place and mode of death and reinfarction during a period of five years after acute myocardial infarction in diabetic and non-diabetic patients. Cardiology 1996; 87:423-8.
4. Brogan GX, Peterson ED, Mulgund J, Bhatt DL, Oham EM, Gilber WB, et al. Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care 2006; 29:9-14.
5. Aronson D, Rayfield E, Cheseboro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126:296-306.
6. Sodi-Pallares D, Testelli MR, Fishleder B. Effects of intravenous infusion of potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9:116-81.
7. Fath-Ordoubadi F, Beatt K. Glucose-insulin-potassium therapy for treatment of myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997; 96:1074-7.
8. Malmberg K, for the DIGAMI study group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J 1997; 314:1512-15.
9. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:771-8.
10. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207-14.
11. Lawrence IG, Davies MJ. Diabetes and myocardial infarction: Do we have time to wait? Pract Diabetes Int 1999; 16:43-6.
12. Fisher BM. Diabetes mellitus and myocardial infarction: A time to act or a time to wait? Diabetic Med 1998; 15:275.
13. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infraction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005; 26:650-61.
14. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-67.
15. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in critically ill: Insulin dose versus glycaemic control. Crit Care Med 2003; 31:359-66.
16. Opie L. The glucose hypothesis: Relation to acute myocardial ischaemia. J Mol Cell Cardiol 1970; 1:107-14.
17. Hansen T, Thiel S, Wouters P, Christiansen J, Van den Berghe B. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-gind lectin levels. J Clin Endocrinol Metab 2003; 88:1082-8.
18. Messoten D, Swinnen J, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycaemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89:219-26.